Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles

Controlling metastasis is an important strategy in cancer treatment. Nanotechnology and nucleic acids with novel modalities are promising regulators of cancer metastasis. We aimed to develop a small interfering RNA (siRNA) systemic delivery and anti-metastasis system using nanotechnology. We previou...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisako Ibaraki (Author), Takanori Kanazawa (Author), Minami Owada (Author), Keiko Iwaya (Author), Yuuki Takashima (Author), Yasuo Seta (Author)
Format: Book
Published: MDPI AG, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_aae82fe17a0849f5b4b67eddb25b1ce6
042 |a dc 
100 1 0 |a Hisako Ibaraki  |e author 
700 1 0 |a Takanori Kanazawa  |e author 
700 1 0 |a Minami Owada  |e author 
700 1 0 |a Keiko Iwaya  |e author 
700 1 0 |a Yuuki Takashima  |e author 
700 1 0 |a Yasuo Seta  |e author 
245 0 0 |a Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles 
260 |b MDPI AG,   |c 2020-01-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics12010064 
520 |a Controlling metastasis is an important strategy in cancer treatment. Nanotechnology and nucleic acids with novel modalities are promising regulators of cancer metastasis. We aimed to develop a small interfering RNA (siRNA) systemic delivery and anti-metastasis system using nanotechnology. We previously reported that polyethylene glycol-polycaprolactone (PEG-PCL) and functional peptide CH2R4H2C nano-micelle (MPEG-PCL-CH2R4H2C) has high siRNA silencing effects, indicated by increased drug accumulation in tumor-bearing mice, and has an anti-tumor effect on solid tumors upon systemic injection. In this study, we aimed to apply our micelles to inhibit metastasis and evaluated the inhibitory effect of anti-RelA siRNA (siRelA), which is a subunit of NF-κB conjugated with MPEG-PCL-CH2R4H2C, via systemic administration. We report that siRelA/MPEG-PCL-CH2R4H2C had a high cellular uptake and suppressed the migration/invasion of cells in B16F10 cells without toxicity. In addition, in a lung metastasis mouse model using intravenous administration of B16F10 cells treated with siRelA/MPEG-PCL-CH2R4H2C, the number of lung nodules in lung tissue significantly decreased compared to naked siRelA and siControl/MPEG-PCL-CH2R4H2C micelle treatments. Hence, we show that RelA expression can reduce cancer metastasis, and MPEG-PCL-CH2R4H2C is an effective siRNA carrier for anti-metastasis cancer therapies. 
546 |a EN 
690 |a polymer nano-micelles 
690 |a sirna 
690 |a systemic delivery 
690 |a metastasis 
690 |a melanoma 
690 |a nf-κb 
690 |a rela 
690 |a functional peptide 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 1, p 64 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/1/64 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/aae82fe17a0849f5b4b67eddb25b1ce6  |z Connect to this object online.